Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Mild Cognitive Impairment (MCI) is considered a transitional stage in the pathogenesis of Alzheimer’s disease; however, not all MCI patients progress to clinically defined AD or decline at identical rates. Hippocampal atrophy, as measured by Magnetic Resonance Imaging (MRI), may be a marker for hippocampal pathology in patients with MCI and predict a more rapid deterioration to clinical AD. In this study, we used MRI data from an ongoing MCI clinical trial to determine whether MRI hippocampal volume at baseline was associated with cognitive and functional performance in MCI subjects and whether it predicted those individuals who were more likely to develop AD. We performed correlational analyses between the MRI hippocampal volumes at study entry and the subjects’ concurrent performance on neuropsychological measures and clinical ratings. Larger hippocampal volume was associated with better performance on tests of memory, general cognition, and overall clinical ratings. Further analyses suggested that a smaller baseline hippocampal volume may be associated with a higher risk of developing clinical AD. As the trial is still ongoing, these results require confirmation once the trial is completed. In summary, these data suggest that MRI hippocampal volume may be a useful correlate of disease severity in MCI subjects and a prognostic indicator of subsequent AD.
- Folstein M. F., Folstein S. E., McHugh P. R. (1975) “Minimental state.” A practical method for grading the cognitive state of patients for the clinician. J. Psychiatric Res. 12, 189–198. CrossRef
- Grundman M., Petersen R. C., Morris J. C., et al. (1996) Rate of dementia of Alzheimer type (DAT) in subjects with mild cognitive impairment. The ADCS Cooperative Study. Neurology 46, A403.
- Jack C. R., Jr., Bentley M., Twomey C. K., and Zinsmeister A. R. (1990) MR-based volume measurements of the hippocampal formation and anterior temporal lobe: validation studies. Radiology 176, 205–209.
- Jack C. R., Petersen R. C., Xu Y., et al. (2000) Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55, 484–489.
- Jack C. R., Jr., Petersen R. C., Xu Y. C., et al. (1999) Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52, 1397–1403.
- Jack C. R., Jr., Petersen R. C., Xu Y. C., et al. (1997) Medial temporal atrophy on MRI in normal aging and very mild Alzheimer’s disease. Neurology 49, 786–794.
- Morris J. C. (1997) Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int. Psychogeriatr. 9, 173–176; discussion 177–178. CrossRef
- Petersen R. C., Smith G. E., Ivnik R. J., et al. (1995) Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals. JAMA 273, 1274–1278. CrossRef
- Petersen R. C., Smith G. E., Waring S. C., Ivnik R. J., Tangalos E. G., and Kokmen E. (1999) Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56, 303–308. CrossRef
- Rosen W. G., Mohs R. C., and Davis K. L. (1984) A new rating scale for Alzheimer’s disease. Am. J. Psychiatry 141, 1356–1364.
- Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial
Journal of Molecular Neuroscience
Volume 19, Issue 1-2 , pp 23-27
- Cover Date
- Print ISSN
- Online ISSN
- Humana Press
- Additional Links
- Mild Cognitive Impairment
- Clinical trial
- Hippocampal volume
- Alzheimer’s disease
- Industry Sectors
- Author Affiliations
- 1. Department of Neurosciences, University of California, San Diego, La Jolla, CA
- 3. Departments of Diagnostic Radiology, Neurology, Mayo Clinic and Foundation, Rochester, MN
- 4. Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX
- 5. Department of Neurology, University of California, Davis, CA
- 6. Department of Neurology, University of Pittsburgh, Pittsburgh, PA
- 7. Department of Psychiatry, Yale University School of Medicine, New Haven, CT